Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-12

AUTHORS

Gough G Au, Leone G Beagley, Erin S Haley, Richard D Barry, Darren R Shafren

ABSTRACT

Many RNA viruses are displaying great promise in the field of oncolytic virotherapy. Previously, we reported that the picornavirus Coxsackievirus A21 (CVA21) possessed potent oncolytic activity against cultured malignant melanoma cells and melanoma xenografts in mice. In the present study, we demonstrate that three additional Group A Coxsackieviruses; Coxsackievirus A13 (CVA13), Coxsackievirus A15 (CVA15) and Coxsackievirus A18 (CVA18), also have similar oncolytic activity against malignant melanoma. Each of the viruses grew quickly to high titers in cancer cells expressing ICAM-1 and intratumoral injection of preformed subcutaneous SK-Mel-28 xenografts in mice with CVA13, CVA15 and CVA18 resulted in significant tumor volume reduction.As preexisting immunity could potentially hinder oncolytic virotherapy, sera from stage IV melanoma patients and normal controls were tested for levels of protective antibody against the panel of oncolytic Coxsackieviruses. Serum neutralization assays revealed that 3 of 21 subjects possessed low levels of anti-CVA21 antibodies, while protective antibodies for CVA13, CVA15 and CVA18 were not detected in any sample. Serum from individuals who were seropositive for CVA21 failed to exhibit cross-neutralization of CVA13, CVA15 and CVA18. From these studies it can be concluded that the administration of CVA13, CVA15 or CVA18 could be employed as a potential multivalent oncolytic therapy against malignant melanoma. More... »

PAGES

22

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1743-422x-8-22

DOI

http://dx.doi.org/10.1186/1743-422x-8-22

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022936737

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21241513


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Neutralizing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enterovirus A, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncolytic Virotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncolytic Viruses", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Heterologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Viral Load", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, The School of Biomedical Sciences and Pharmacy, Faculty of Health, The University of Newcastle, 2300, Newcastle, New South Wales, Australia", 
            "Newcastle Innovation Ltd, Industry Development Centre, University Drv, 2308, Callaghan, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Au", 
        "givenName": "Gough G", 
        "id": "sg:person.0723674343.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723674343.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Newcastle Innovation Ltd, Industry Development Centre, University Drv, 2308, Callaghan, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beagley", 
        "givenName": "Leone G", 
        "id": "sg:person.01100166220.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100166220.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, The School of Biomedical Sciences and Pharmacy, Faculty of Health, The University of Newcastle, 2300, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haley", 
        "givenName": "Erin S", 
        "id": "sg:person.01101304732.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101304732.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, The School of Biomedical Sciences and Pharmacy, Faculty of Health, The University of Newcastle, 2300, Newcastle, New South Wales, Australia", 
            "Newcastle Innovation Ltd, Industry Development Centre, University Drv, 2308, Callaghan, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barry", 
        "givenName": "Richard D", 
        "id": "sg:person.01134100502.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134100502.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, The School of Biomedical Sciences and Pharmacy, Faculty of Health, The University of Newcastle, 2300, Newcastle, New South Wales, Australia", 
            "Viralytics, Viralytics Ltd, Suite 1B, Grandview St, 55-63, 2073, Pymble, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shafren", 
        "givenName": "Darren R", 
        "id": "sg:person.0750717567.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750717567.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00403-005-0605-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001269028", 
          "https://doi.org/10.1007/s00403-005-0605-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00403-005-0605-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001269028", 
          "https://doi.org/10.1007/s00403-005-0605-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(59)91779-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005628598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sap.0b013e3181cf9f32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006321390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sap.0b013e3181cf9f32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006321390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sap.0b013e3181cf9f32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006321390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-0719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023690263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00202069", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031738938", 
          "https://doi.org/10.1007/bf00202069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00202069", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031738938", 
          "https://doi.org/10.1007/bf00202069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.86.2.641", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033313532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0171-2985(88)80071-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040829864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006304806799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044128575", 
          "https://doi.org/10.1023/a:1006304806799"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1537-2995.2003.00463.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045195260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-0690-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053385375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1099/vir.0.19329-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060399989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.26.6.1471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071515724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075862144", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083089727", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-12", 
    "datePublishedReg": "2011-12-01", 
    "description": "Many RNA viruses are displaying great promise in the field of oncolytic virotherapy. Previously, we reported that the picornavirus Coxsackievirus A21 (CVA21) possessed potent oncolytic activity against cultured malignant melanoma cells and melanoma xenografts in mice. In the present study, we demonstrate that three additional Group A Coxsackieviruses; Coxsackievirus A13 (CVA13), Coxsackievirus A15 (CVA15) and Coxsackievirus A18 (CVA18), also have similar oncolytic activity against malignant melanoma. Each of the viruses grew quickly to high titers in cancer cells expressing ICAM-1 and intratumoral injection of preformed subcutaneous SK-Mel-28 xenografts in mice with CVA13, CVA15 and CVA18 resulted in significant tumor volume reduction.As preexisting immunity could potentially hinder oncolytic virotherapy, sera from stage IV melanoma patients and normal controls were tested for levels of protective antibody against the panel of oncolytic Coxsackieviruses. Serum neutralization assays revealed that 3 of 21 subjects possessed low levels of anti-CVA21 antibodies, while protective antibodies for CVA13, CVA15 and CVA18 were not detected in any sample. Serum from individuals who were seropositive for CVA21 failed to exhibit cross-neutralization of CVA13, CVA15 and CVA18. From these studies it can be concluded that the administration of CVA13, CVA15 or CVA18 could be employed as a potential multivalent oncolytic therapy against malignant melanoma.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1743-422x-8-22", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1034449", 
        "issn": [
          "1743-422X"
        ], 
        "name": "Virology Journal", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18", 
    "pagination": "22", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6d4679e91ea5aa6399afb3ce438f1fe17dc8e2c7d22210fbc2ebb39192532736"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21241513"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101231645"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1743-422x-8-22"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022936737"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1743-422x-8-22", 
      "https://app.dimensions.ai/details/publication/pub.1022936737"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1743-422X-8-22"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-8-22'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-8-22'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-8-22'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1743-422x-8-22'


 

This table displays all metadata directly associated to this object as RDF triples.

203 TRIPLES      21 PREDICATES      58 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1743-422x-8-22 schema:about N0376be14bbcb4387bd2faaa46bb37104
2 N0f58d6344d9748b6b609ce4837a1b1fd
3 N2922c33529774fb0adbd33b51e141631
4 N5768fd6dea7b49e09519b0fe3ba5c711
5 N851022b5278b48558b48dd6f8119a7cb
6 N85ebe684699d4b698ea98e82b153cc57
7 N8cce358b94cb40eabaea8627906fb674
8 N996e30b347864b81ac2f591514d79300
9 Na19a97f21695419491dfe2153345e5cf
10 Nb6745fae869d4e74ae61f842eeb9b923
11 Nc9b9132884dd4dcebaee1417fd03594e
12 Ne122b256a2864a588311340c59ab5b68
13 Nfc41582c097b4e78bb1e4800658aeb4d
14 Nfcce730d16434a68989b1ff55fffb819
15 Nfec7dbe2545248999cb6742207852e36
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N1d442eade3e34823b1492b584130e0b4
19 schema:citation sg:pub.10.1007/bf00202069
20 sg:pub.10.1007/s00403-005-0605-5
21 sg:pub.10.1023/a:1006304806799
22 https://app.dimensions.ai/details/publication/pub.1075862144
23 https://app.dimensions.ai/details/publication/pub.1083089727
24 https://doi.org/10.1016/s0140-6736(59)91779-9
25 https://doi.org/10.1016/s0171-2985(88)80071-8
26 https://doi.org/10.1046/j.1537-2995.2003.00463.x
27 https://doi.org/10.1073/pnas.86.2.641
28 https://doi.org/10.1097/sap.0b013e3181cf9f32
29 https://doi.org/10.1099/vir.0.19329-0
30 https://doi.org/10.1158/0008-5472.can-08-0719
31 https://doi.org/10.1158/1078-0432.ccr-0690-3
32 https://doi.org/10.3892/ijo.26.6.1471
33 schema:datePublished 2011-12
34 schema:datePublishedReg 2011-12-01
35 schema:description Many RNA viruses are displaying great promise in the field of oncolytic virotherapy. Previously, we reported that the picornavirus Coxsackievirus A21 (CVA21) possessed potent oncolytic activity against cultured malignant melanoma cells and melanoma xenografts in mice. In the present study, we demonstrate that three additional Group A Coxsackieviruses; Coxsackievirus A13 (CVA13), Coxsackievirus A15 (CVA15) and Coxsackievirus A18 (CVA18), also have similar oncolytic activity against malignant melanoma. Each of the viruses grew quickly to high titers in cancer cells expressing ICAM-1 and intratumoral injection of preformed subcutaneous SK-Mel-28 xenografts in mice with CVA13, CVA15 and CVA18 resulted in significant tumor volume reduction.As preexisting immunity could potentially hinder oncolytic virotherapy, sera from stage IV melanoma patients and normal controls were tested for levels of protective antibody against the panel of oncolytic Coxsackieviruses. Serum neutralization assays revealed that 3 of 21 subjects possessed low levels of anti-CVA21 antibodies, while protective antibodies for CVA13, CVA15 and CVA18 were not detected in any sample. Serum from individuals who were seropositive for CVA21 failed to exhibit cross-neutralization of CVA13, CVA15 and CVA18. From these studies it can be concluded that the administration of CVA13, CVA15 or CVA18 could be employed as a potential multivalent oncolytic therapy against malignant melanoma.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree true
39 schema:isPartOf N021c9b664dc444798ca7347aa187aec8
40 Nc504a35eed1b4906a6cf3d70ba91e825
41 sg:journal.1034449
42 schema:name Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
43 schema:pagination 22
44 schema:productId N0aa648af9efd456185f6de4e90b8cbd9
45 N68a10871e4374fb6853d51de2d970614
46 N6bf331054749442fa1d7c951861c9684
47 N818d0eaca0cc49f5b41419b3b934fc5b
48 Ndc20d96178a84df78ca79b0c69365891
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022936737
50 https://doi.org/10.1186/1743-422x-8-22
51 schema:sdDatePublished 2019-04-11T02:00
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N7736ed55978a418fadec79202fa82756
54 schema:url http://link.springer.com/10.1186%2F1743-422X-8-22
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N021c9b664dc444798ca7347aa187aec8 schema:volumeNumber 8
59 rdf:type schema:PublicationVolume
60 N0376be14bbcb4387bd2faaa46bb37104 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Disease Models, Animal
62 rdf:type schema:DefinedTerm
63 N0aa648af9efd456185f6de4e90b8cbd9 schema:name dimensions_id
64 schema:value pub.1022936737
65 rdf:type schema:PropertyValue
66 N0f58d6344d9748b6b609ce4837a1b1fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Transplantation, Heterologous
68 rdf:type schema:DefinedTerm
69 N1d442eade3e34823b1492b584130e0b4 rdf:first sg:person.0723674343.44
70 rdf:rest N74a60020a8c5465192580821a0734686
71 N2922c33529774fb0adbd33b51e141631 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Skin Neoplasms
73 rdf:type schema:DefinedTerm
74 N2db867ee78f348209dd526392fafd098 rdf:first sg:person.01134100502.12
75 rdf:rest Ne58e0a584df64de980ee72f422385856
76 N56c478c916cc4920a6e55a411de22f46 schema:name Newcastle Innovation Ltd, Industry Development Centre, University Drv, 2308, Callaghan, New South Wales, Australia
77 rdf:type schema:Organization
78 N5768fd6dea7b49e09519b0fe3ba5c711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Antibodies, Viral
80 rdf:type schema:DefinedTerm
81 N68a10871e4374fb6853d51de2d970614 schema:name nlm_unique_id
82 schema:value 101231645
83 rdf:type schema:PropertyValue
84 N6bf331054749442fa1d7c951861c9684 schema:name pubmed_id
85 schema:value 21241513
86 rdf:type schema:PropertyValue
87 N74a60020a8c5465192580821a0734686 rdf:first sg:person.01100166220.18
88 rdf:rest Nee0459838c7f40019ffcda6d5ab134aa
89 N7736ed55978a418fadec79202fa82756 schema:name Springer Nature - SN SciGraph project
90 rdf:type schema:Organization
91 N818d0eaca0cc49f5b41419b3b934fc5b schema:name doi
92 schema:value 10.1186/1743-422x-8-22
93 rdf:type schema:PropertyValue
94 N851022b5278b48558b48dd6f8119a7cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Antibodies, Neutralizing
96 rdf:type schema:DefinedTerm
97 N85ebe684699d4b698ea98e82b153cc57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Viral Load
99 rdf:type schema:DefinedTerm
100 N8cce358b94cb40eabaea8627906fb674 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 N996e30b347864b81ac2f591514d79300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Enterovirus A, Human
105 rdf:type schema:DefinedTerm
106 Na19a97f21695419491dfe2153345e5cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Oncolytic Virotherapy
108 rdf:type schema:DefinedTerm
109 Nb6745fae869d4e74ae61f842eeb9b923 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Oncolytic Viruses
111 rdf:type schema:DefinedTerm
112 Nc504a35eed1b4906a6cf3d70ba91e825 schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 Nc9b9132884dd4dcebaee1417fd03594e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Animals
116 rdf:type schema:DefinedTerm
117 Ndc20d96178a84df78ca79b0c69365891 schema:name readcube_id
118 schema:value 6d4679e91ea5aa6399afb3ce438f1fe17dc8e2c7d22210fbc2ebb39192532736
119 rdf:type schema:PropertyValue
120 Ne122b256a2864a588311340c59ab5b68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Cell Line, Tumor
122 rdf:type schema:DefinedTerm
123 Ne58e0a584df64de980ee72f422385856 rdf:first sg:person.0750717567.49
124 rdf:rest rdf:nil
125 Nee0459838c7f40019ffcda6d5ab134aa rdf:first sg:person.01101304732.75
126 rdf:rest N2db867ee78f348209dd526392fafd098
127 Nfc41582c097b4e78bb1e4800658aeb4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 Nfcce730d16434a68989b1ff55fffb819 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Melanoma
132 rdf:type schema:DefinedTerm
133 Nfec7dbe2545248999cb6742207852e36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Mice
135 rdf:type schema:DefinedTerm
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
140 schema:name Oncology and Carcinogenesis
141 rdf:type schema:DefinedTerm
142 sg:journal.1034449 schema:issn 1743-422X
143 schema:name Virology Journal
144 rdf:type schema:Periodical
145 sg:person.01100166220.18 schema:affiliation N56c478c916cc4920a6e55a411de22f46
146 schema:familyName Beagley
147 schema:givenName Leone G
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100166220.18
149 rdf:type schema:Person
150 sg:person.01101304732.75 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
151 schema:familyName Haley
152 schema:givenName Erin S
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101304732.75
154 rdf:type schema:Person
155 sg:person.01134100502.12 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
156 schema:familyName Barry
157 schema:givenName Richard D
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134100502.12
159 rdf:type schema:Person
160 sg:person.0723674343.44 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
161 schema:familyName Au
162 schema:givenName Gough G
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723674343.44
164 rdf:type schema:Person
165 sg:person.0750717567.49 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
166 schema:familyName Shafren
167 schema:givenName Darren R
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750717567.49
169 rdf:type schema:Person
170 sg:pub.10.1007/bf00202069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031738938
171 https://doi.org/10.1007/bf00202069
172 rdf:type schema:CreativeWork
173 sg:pub.10.1007/s00403-005-0605-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001269028
174 https://doi.org/10.1007/s00403-005-0605-5
175 rdf:type schema:CreativeWork
176 sg:pub.10.1023/a:1006304806799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044128575
177 https://doi.org/10.1023/a:1006304806799
178 rdf:type schema:CreativeWork
179 https://app.dimensions.ai/details/publication/pub.1075862144 schema:CreativeWork
180 https://app.dimensions.ai/details/publication/pub.1083089727 schema:CreativeWork
181 https://doi.org/10.1016/s0140-6736(59)91779-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005628598
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/s0171-2985(88)80071-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040829864
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1046/j.1537-2995.2003.00463.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045195260
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1073/pnas.86.2.641 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033313532
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1097/sap.0b013e3181cf9f32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006321390
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1099/vir.0.19329-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060399989
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1158/0008-5472.can-08-0719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023690263
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1158/1078-0432.ccr-0690-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053385375
196 rdf:type schema:CreativeWork
197 https://doi.org/10.3892/ijo.26.6.1471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071515724
198 rdf:type schema:CreativeWork
199 https://www.grid.ac/institutes/grid.266842.c schema:alternateName University of Newcastle Australia
200 schema:name Newcastle Innovation Ltd, Industry Development Centre, University Drv, 2308, Callaghan, New South Wales, Australia
201 The Picornaviral Research Unit, The School of Biomedical Sciences and Pharmacy, Faculty of Health, The University of Newcastle, 2300, Newcastle, New South Wales, Australia
202 Viralytics, Viralytics Ltd, Suite 1B, Grandview St, 55-63, 2073, Pymble, New South Wales, Australia
203 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...